Helen M. Thackray - Insider Trading & Ownership

Entity
Individual
Location
C/O Glycomimetics, Inc., 401 Professional Drive, Suite 250, Gaithersburg, MD
Summary
The estimated net worth of Helen M. Thackray is at least $2M dollars as of December 17, 2024. Helen M. Thackray is the Chief R&D Officer of BIOCRYST PHARMACEUTICALS INC and owns shares of BIOCRYST PHARMACEUTICALS INC (BCRX) stock worth about $2M.
All Insider Reports
All Insider Reports

Ownership of Helen M. Thackray

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BCRX BIOCRYST PHARMACEUTICALS INC Chief R&D Officer $2M +$176K +9.66% Dec 14, 2024
IMGN ImmunoGen, Inc. Director $0 Feb 12, 2024

Insider Transactions Reported by Helen M. Thackray:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.